DR. JANINA PAULA TIULENTINO SY-GO M.D.
Prescription History 1043661549
Internal Medicine - Nephrology in Honolulu, HI

NPI Status: Active since June 27, 2016

Contact Information

1356 LUSITANA ST FL 7
HONOLULU, HI
ZIP 96813
Phone: (808) 462-7662

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. JANINA PAULA TIULENTINO SY-GO M.D., an active Nephrology specialist practicing in Honolulu, HI. Our medical registry currently tracks 10 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 238 documented patient claims. Among these therapy options, the most frequently utilized medication is Farxiga, which accounts for 36 claims alone.


Allopurinol

Generic Formulation: AllopurinolSpecialty: Nephrology
Provider Metrics Summary
Total Claims 14
30-Day Fills 28.0
Days Supply 840
HI State Average Benchmarks
Peer Average Claims60.0
Peer Average 30-Day Fills165.6
Peer Average Days Supply4,959
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 76.7% less volume than the regional standard for practitioners inside HI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $238.30 across this reporting matrix range.

Provider Avg Cost Per Claim

$17.02

State Avg Cost Per Claim

$16.62

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms.

Therapeutic Applications

Allopurinol is used to treat gout and certain types of kidney stones. It is also used to prevent increased uric acid levels in patients receiving cancer chemotherapy. These patients can have increased uric acid levels due to release of uric acid from the dying cancer cells. Allopurinol works by reducing the amount of uric acid made by the body. Increased uric acid levels can cause gout and kidney problems.

Amlodipine Besylate

Generic Formulation: Amlodipine BesylateSpecialty: Nephrology
Provider Metrics Summary
Total Claims 34
30-Day Fills 76.5
Days Supply 2,295
HI State Average Benchmarks
Peer Average Claims133.0
Peer Average 30-Day Fills358.7
Peer Average Days Supply10,736
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 74.4% less volume than the regional standard for practitioners inside HI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $446.90 across this reporting matrix range.

Provider Avg Cost Per Claim

$13.14

State Avg Cost Per Claim

$6.73

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.

Therapeutic Applications

Amlodipine is used with or without other medications to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Amlodipine belongs to a class of drugs known as calcium channel blockers. It works by relaxing blood vessels so blood can flow more easily. Amlodipine is also used to prevent certain types of chest pain (angina). It may help to increase your ability to exercise and decrease the frequency of angina attacks. It should not be used to treat attacks of chest pain when they occur. Use other medications (such as sublingual nitroglycerin) to relieve attacks of chest pain as directed by your doctor.

Chlorthalidone

Generic Formulation: ChlorthalidoneSpecialty: Nephrology
Provider Metrics Summary
Total Claims 31
30-Day Fills 91.0
Days Supply 2,730
HI State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills72.1
Peer Average Days Supply2,159
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across HI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,414.08 across this reporting matrix range.

Provider Avg Cost Per Claim

$45.62

State Avg Cost Per Claim

$31.56

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzenesulfonamide-phthalimidine that tautomerizes to a BENZOPHENONES form. It is considered a thiazide-like diuretic.

Therapeutic Applications

Chlorthalidone is used to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to reduce extra salt and water in the body caused by conditions such as heart failure, liver disease, and kidney disease. Decreasing extra salt and water in the body helps to decrease swelling (edema) and breathing problems caused by fluid in the lungs. Chlorthalidone is a water pill (diuretic). It increases the amount of urine you make, especially when you first start the medication. It also helps to relax the blood vessels so that blood can flow more easily.

Farxiga

Generic Formulation: Dapagliflozin PropanediolSpecialty: Nephrology
Provider Metrics Summary
Total Claims 36
30-Day Fills 78.3
Days Supply 2,314
HI State Average Benchmarks
Peer Average Claims45.0
Peer Average 30-Day Fills92.9
Peer Average Days Supply2,778
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across HI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $44,669.09 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,240.81

State Avg Cost Per Claim

$1,125.51

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Dapagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication is also used in people with type 2 diabetes and heart disease to lower the risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sugar by your kidneys. Dapagliflozin is also used to treat kidney disease and heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sodium by your kidneys.

Kerendia

Generic Formulation: FinerenoneSpecialty: Nephrology
Provider Metrics Summary
Total Claims 11
30-Day Fills 23.0
Days Supply 690
HI State Average Benchmarks
Peer Average Claims47.0
Peer Average 30-Day Fills81.1
Peer Average Days Supply2,433
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 76.6% less volume than the regional standard for practitioners inside HI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $14,501.39 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,318.31

State Avg Cost Per Claim

$1,021.70

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Finerenone is used by people with type 2 diabetes and kidney disease to lower the risk of dialysis, death from heart disease, heart attacks, and the need to go to the hospital for heart failure. It works by blocking a chemical (aldosterone) in your body which in turn lowers the amount of sodium and water the body retains.

Lokelma

Generic Formulation: Sodium Zirconium CyclosilicateSpecialty: Nephrology
Provider Metrics Summary
Total Claims 24
30-Day Fills 37.8
Days Supply 1,126
HI State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills39.8
Peer Average Days Supply1,130
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across HI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $27,560.89 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,148.37

State Avg Cost Per Claim

$900.55

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat high levels of potassium in the blood. It works by binding to potassium in the gut. This medication does not work right away, and should not be used to treat life-threatening high levels of potassium. High potassium levels can cause symptoms such as nausea, muscle weakness/tiredness, irregular heartbeats, or paralysis.

Losartan Potassium

Generic Formulation: Losartan PotassiumSpecialty: Nephrology
Provider Metrics Summary
Total Claims 30
30-Day Fills 88.7
Days Supply 2,660
HI State Average Benchmarks
Peer Average Claims136.0
Peer Average 30-Day Fills375.2
Peer Average Days Supply11,239
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 77.9% less volume than the regional standard for practitioners inside HI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $597.59 across this reporting matrix range.

Provider Avg Cost Per Claim

$19.92

State Avg Cost Per Claim

$10.86

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.

Therapeutic Applications

Losartan is used to treat high blood pressure (hypertension) and to help protect the kidneys from damage due to diabetes. It is also used to lower the risk of strokes in patients with high blood pressure and an enlarged heart. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Losartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily.

Olmesartan Medoxomil

Generic Formulation: Olmesartan MedoxomilSpecialty: Nephrology
Provider Metrics Summary
Total Claims 21
30-Day Fills 41.7
Days Supply 1,250
HI State Average Benchmarks
Peer Average Claims42.0
Peer Average 30-Day Fills119.4
Peer Average Days Supply3,581
Conservative Utilization

This provider writes prescriptions for this formulation 50.0% less frequently than the standard regional baseline metric for practitioners inside HI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $924.20 across this reporting matrix range.

Provider Avg Cost Per Claim

$44.01

State Avg Cost Per Claim

$83.39

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER that is used to manage HYPERTENSION.

Therapeutic Applications

Olmesartan is used to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Olmesartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily.

Sevelamer Carbonate

Generic Formulation: Sevelamer CarbonateSpecialty: Nephrology
Provider Metrics Summary
Total Claims 19
30-Day Fills 39.0
Days Supply 1,170
HI State Average Benchmarks
Peer Average Claims82.0
Peer Average 30-Day Fills181.8
Peer Average Days Supply5,435
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 76.8% less volume than the regional standard for practitioners inside HI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,331.87 across this reporting matrix range.

Provider Avg Cost Per Claim

$175.36

State Avg Cost Per Claim

$600.88

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A polymeric amine that binds phosphate and is used to treat HYPERPHOSPHATEMIA in patients with kidney disease.

Therapeutic Applications

Sevelamer is used to lower high blood phosphorus (phosphate) levels in patients who are on dialysis due to severe kidney disease. Dialysis removes some phosphate from your blood, but it is difficult to remove enough to keep your phosphate levels balanced. Decreasing blood phosphate levels can help keep your bones strong, prevent unsafe buildup of minerals in your body, and possibly decrease the risk of heart disease and strokes that can result from high phosphate levels. Sevelamer works by holding onto phosphate from the diet so that it can pass out of your body.

Torsemide

Generic Formulation: TorsemideSpecialty: Nephrology
Provider Metrics Summary
Total Claims 18
30-Day Fills 44.0
Days Supply 1,320
HI State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills61.5
Peer Average Days Supply1,824
Conservative Utilization

This provider writes prescriptions for this formulation 33.3% less frequently than the standard regional baseline metric for practitioners inside HI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $730.89 across this reporting matrix range.

Provider Avg Cost Per Claim

$40.61

State Avg Cost Per Claim

$28.23

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyridine and sulfonamide derivative that acts as a sodium-potassium chloride symporter inhibitor (loop diuretic). It is used for the treatment of EDEMA associated with CONGESTIVE HEART FAILURE; CHRONIC RENAL INSUFFICIENCY; and LIVER DISEASES. It is also used for the management of HYPERTENSION.

Therapeutic Applications

Torsemide is used to reduce extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, and kidney disease. This can lessen symptoms such as shortness of breath and swelling in your arms, legs, and abdomen. This drug is also used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Torsemide is a water pill (diuretic) that causes you to make more urine. This helps your body get rid of extra water and salt.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. JANINA PAULA TIULENTINO SY-GO M.D. provides transparency into local medical care patterns within Honolulu, HI.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Nephrology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.